27 related articles for article (PubMed ID: 17705048)
1. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses.
Saxena V; Piao W; Li L; Paluskievicz C; Xiong Y; Simon T; Lakhan R; Brinkman CC; Walden S; Hippen KL; WillsonShirkey M; Lee YS; Wagner C; Blazar BR; Bromberg JS
Cell Rep; 2022 Apr; 39(3):110727. PubMed ID: 35443187
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota and Serum Metabolic Signatures of High-Fat-Induced Bone Loss in Mice.
Lu L; Tang M; Li J; Xie Y; Li Y; Xie J; Zhou L; Liu Y; Yu X
Front Cell Infect Microbiol; 2021; 11():788576. PubMed ID: 35004355
[TBL] [Abstract][Full Text] [Related]
3. Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression.
Corciulo C; Lendhey M; Wilder T; Schoen H; Cornelissen AS; Chang G; Kennedy OD; Cronstein BN
Nat Commun; 2017 May; 8():15019. PubMed ID: 28492224
[TBL] [Abstract][Full Text] [Related]
4. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
5. Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist.
He W; Wilder T; Cronstein BN
Br J Pharmacol; 2013 Nov; 170(6):1167-76. PubMed ID: 23962057
[TBL] [Abstract][Full Text] [Related]
6. Purinergic signalling in the musculoskeletal system.
Burnstock G; Arnett TR; Orriss IR
Purinergic Signal; 2013 Dec; 9(4):541-72. PubMed ID: 23943493
[TBL] [Abstract][Full Text] [Related]
7. Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.
Vincenzi F; Targa M; Corciulo C; Gessi S; Merighi S; Setti S; Cadossi R; Goldring MB; Borea PA; Varani K
PLoS One; 2013; 8(5):e65561. PubMed ID: 23741498
[TBL] [Abstract][Full Text] [Related]
8. Adenosine and bone metabolism.
Mediero A; Cronstein BN
Trends Endocrinol Metab; 2013 Jun; 24(6):290-300. PubMed ID: 23499155
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.
He W; Cronstein BN
Purinergic Signal; 2012 Jun; 8(2):327-37. PubMed ID: 22311477
[TBL] [Abstract][Full Text] [Related]
10. Adenosine in the airways: implications and applications.
Spicuzza L; Di Maria G; Polosa R
Eur J Pharmacol; 2006 Mar; 533(1-3):77-88. PubMed ID: 16458886
[TBL] [Abstract][Full Text] [Related]
11. Interplay of hypoxia and A2B adenosine receptors in tissue protection.
Koeppen M; Eckle T; Eltzschig HK
Adv Pharmacol; 2011; 61():145-86. PubMed ID: 21586359
[TBL] [Abstract][Full Text] [Related]
12. Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63.
Russell JM; Stephenson GS; Yellowley CE; Benton HP
Calcif Tissue Int; 2007 Oct; 81(4):316-26. PubMed ID: 17705048
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
14. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms involved in the adenosine A and A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary cultures.
Canals M; Angulo E; Casadó V; Canela EI; Mallol J; Viñals F; Staines W; Tinner B; Hillion J; Agnati L; Fuxe K; Ferré S; Lluis C; Franco R
J Neurochem; 2005 Jan; 92(2):337-48. PubMed ID: 15663481
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]